Cargando…
Providing open-label placebos remotely—A randomized controlled trial in allergic rhinitis
BACKGROUND: Placebos can reduce physical symptoms even when provided with full honesty and disclosure. Yet, the precise mechanisms underlying the effects of “open-label placebos” (OLPs) have remained subject of debate. Furthermore, it is unclear whether OLPs are similarly effective when provided rem...
Autores principales: | Kube, Tobias, Hofmann, Verena E., Glombiewski, Julia A., Kirsch, Irving |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951912/ https://www.ncbi.nlm.nih.gov/pubmed/33705475 http://dx.doi.org/10.1371/journal.pone.0248367 |
Ejemplares similares
-
Correction: Providing open-label placebos remotely—A randomized controlled trial in allergic rhinitis
por: Kube, Tobias, et al.
Publicado: (2021) -
Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis
por: Schaefer, Michael, et al.
Publicado: (2018) -
A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis
por: Schaefer, Michael, et al.
Publicado: (2023) -
Open-label placebo treatment in chronic low back pain: a randomized controlled trial
por: Carvalho, Cláudia, et al.
Publicado: (2016) -
No Evidence for the Involvement of Cognitive Immunisation in Updating Beliefs About the Self in Three Non-Clinical Samples
por: Kube, Tobias, et al.
Publicado: (2021)